Flora Peyvandi/X
Sep 29, 2025, 12:54
Microfluidic Technology Uncovers Ongoing TTP Disease Activity
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission”
Title: A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission
Authors: Adela Constantinescu-Bercu, Sabina McCann, Bertina Dragunaite, Raphael Sivera, Yishi Tan, Louisa Keogh, Karen Vanhoorelbeke, Heidi Rossmann, Bernhard Lämmle, Rens de Groot, Marie Scully
Read the full article here.
Stay updated with Hemostasis Today.
Adela Constantinescu-Bercu
Bernhard Lämmle
Bertina Dragunaite
Flora Peyvandi
Health
Heidi Rossmann
Hematology
Hemostasis
Hemostasis Today
Karen Vanhoorelbeke
Louisa Keogh
Marie Scully
Medicine
microfluidic approach
Raphael Sivera
Rens de Groot
Sabina McCann
Thrombotic thrombocytopenic purpura
Yishi Tan
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS